| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $339 K | +12.4 K | +14.95% | $27.34 | 95.4 K | Feb 23, 2024 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | -$23.8 K | -859 | -0.9% | $27.76 | 94.5 K | Feb 23, 2024 | Direct | F2 |
| transaction | PFE | Common Stock | Tax liability | -$275 K | -10 K | -10.61% | $27.37 | 84.5 K | Feb 23, 2024 | Direct | F3, F4 |
| transaction | PFE | Common Stock | Tax liability | -$83.1 K | -2.99 K | -3.54% | $27.76 | 81.5 K | Feb 25, 2024 | Direct | F5, F6 |
| transaction | PFE | Common Stock | Tax liability | -$165 K | -6.06 K | -7.44% | $27.18 | 75.5 K | Feb 26, 2024 | Direct | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -12.4 K | -100% | $0.00 | 0 | Feb 23, 2024 | Common Stock | 12.4 K | $27.34 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F3 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F4 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| F5 | The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |
| F6 | Price is the closing price of Pfizer common stock on February 23, 2024. |
| F7 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |